BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4145870)

  • 1. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 3. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
    Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
    Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 7. Learning, brain noradrenaline and the pituitary--adrenal axis.
    Ogren SO; Fuxe K
    Med Biol; 1974 Dec; 52(6):399-405. PubMed ID: 4374613
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior.
    Breese GR; Smith RD; Cooper BR
    Pharmacol Biochem Behav; 1975; 3(6):1097-106. PubMed ID: 4816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 6-hydroxydopamine administration to neonatal rats on some endocrine and behavioral parameters.
    van Delft AM; Nyakas C; Kaplanski J; Tilders FJ
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):403-4. PubMed ID: 4778634
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of behavior in the rat by cyclazocine: effects of naloxone.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1973 Nov; 187(2):380-90. PubMed ID: 4748554
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1972 Feb; 44(2):210-22. PubMed ID: 4148915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic influences on dopamine-dependent behaviour in rats [proceedings].
    Pycock C
    Br J Pharmacol; 1976 Jul; 57(3):424P. PubMed ID: 974325
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
    Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
    Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine.
    Neill DB; Boggan WO; Grossman SP
    Pharmacol Biochem Behav; 1974; 2(1):97-103. PubMed ID: 4597522
    [No Abstract]   [Full Text] [Related]  

  • 16. Central effects of 6-hydroxydopamine.
    Longo VG
    Behav Biol; 1973 Oct; 9(4):397-420. PubMed ID: 4200735
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of response to continuous auditory stimulation in rats treated neonatally with 6-hydroxydopamine.
    Brackbill Y; Douthitt TC
    Dev Psychobiol; 1976 Jan; 9(1):5-15. PubMed ID: 1254106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral teratology of perchloroethylene in rats.
    Nelson BK; Taylor BJ; Setzer JV; Hornung RW
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):233-50. PubMed ID: 547013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.